Xeris Pharmaceuticals | XERS - 股本和储备



金融业
股票价格
USD
资产
USD 383.53M
现金及等价物
USD 111.04M
销售成本
USD 13.66M
流动资产
USD 240.31M
流动负债
USD 109.57M
债务
USD 257.65M
EBIT
USD 16.77M
EBITDA
USD 25.09M
员工
377
EPS每股收益
USD 0.05
股本和储备
USD 13.69M
销售毛利
USD 72.15M
债务利息支出
USD 7.15M
利息收入
USD 1.16M
贷款资金
USD 220.34M
市值
USD 890.5M
净收入
USD 11.08M
营业费用
USD 69.03M
营业利润
USD 16.77M
普通股股本
USD 166.22M
PE价格收益
2.45K
税前利润
USD 11.08M
销售收入
USD 85.81M
销售和管理费用
USD 42.64M
股票
USD 68.67M
贸易债权人
USD 3.08M
应收帐款人
USD 51.05M


股本和储备 更改 日
Celltrion KRW 16.7T 182.36B 2025-09
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 1.2B 707.91M 2026-03
Divis Laboratories Ltd INR 154.13B 4.44B 2025-09
Eli Lilly USD 31.2B 4.66B 2026-03
Kangmei Pharma CNY 7.22B 504.3M 2025-09
Knight Therapeutics CAD 767.27M 480K 2025-12
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 54.77M 335K 2025-12
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
Organigram Holdings CAD 369.46M 20.33M 2025-12
Ovoca Bio EUR 1.26M 7.41M 2025-06
Pacira USD 653.89M 39.22M 2026-03
Perrigo USD 2.94B 1.51B 2025-12
Pharma Mar EUR 249.67M 2.16M 2026-03
Qiagen NV USD 3.78B 128.73M 2025-12
Sartorius EUR 2.73B 1.14B 2026-03
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Supernus Pharmaceuticals USD 1.08B 15.09M 2026-03
Tilray USD 1.58B 39.08M 2025-09
Zealand Pharma A/S 14.83B 331.99M 2025-12
Zz Pientze Pharmaceu CNY 15.21B 740.32M 2026-03